This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

PolyLax (2013-10-16)

Starting date:
October 16, 2013
Posting date:
January 13, 2014
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-36713

Recalled products

  1. PolyLax

Reason

No finished product testing was conducted for this lot.  In addition, there was no evidence to support the shelf life for this lot.

Depth of distribution

Lot was only distributed as samples to physicians in Ontario, Quebec, British Columbia, Alberta, Manitoba.

Affected products

A. PolyLax

DIN, NPN, DIN-HIM
DIN 02330326
Dosage form

Powder for Solution

Strength
  • Polyethylene Glycol 3350, 100%
Lot or serial number
  • Lot 29762
Companies
Recalling Firm
Seaford Pharmaceuticals Inc.
1530 Drew Road, Unit 28
Mississauga
L5S 1W8
Ontario
CANADA
Marketing Authorization Holder
Seaford Pharmaceuticals Inc.
1530 Drew Road, Unit 28
Mississauga
L5S 1W8
Ontario
CANADA

Date modified: